India's CSIR commences Phase II trials of Niclosamide for Covid-19
Niclosamide, STAT3 inhibitor (CAS 50-65-7) (ab120868) | Abcam
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential | ACS Infectious Diseases
California: Don't Count Out Startups in the Fight Against COVID-19 | Site Selection Magazine
Arpimed
Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection - ScienceDirect
In Vitro Evaluation and Mitigation of Niclosamide's Liabilities as a COVID-19 Treatment | bioRxiv
Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects | PLOS Pathogens
Niclosamide reverses adipocyte induced epithelial-mesenchymal transition in breast cancer cells via suppression of the interleukin-6/STAT3 signalling axis | Scientific Reports
Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection - ScienceDirect
Quinacrine and Niclosamide Promote Neurite Growth in Midbrain Dopaminergic Neurons Through the Canonical BMP-Smad Pathway and Protect Against Neurotoxin and α-Synuclein-Induced Neurodegeneration | SpringerLink
Niclosamide - brand name list from Drugs.com
Frontiers | Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis
Lithocholic acid-tryptophan conjugate (UniPR126) based mixed micelle as a nano carrier for specific delivery of niclosamide to prostate cancer via EphA2 receptor - ScienceDirect
Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects | PLOS Pathogens
Niclosamide Exposure at Environmentally Relevant Concentrations Efficaciously Inhibited the Growth and Disturbed the Liver-Gut Axis of Adult Male Zebrafish | Environmental Science & Technology
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling - Gastroenterology
Niclosamide reverses adipocyte induced epithelial-mesenchymal transition in breast cancer cells via suppression of the interleukin-6/STAT3 signalling axis | Scientific Reports
Niclosamide Shows Efficacy Against COVID-19 In Animal Tests According To South Korean Pharmaceutical Giant Daewoong - Thailand Medical News
Frontiers | Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification
A Novel High Content Imaging-Based Screen Identifies the Anti-Helminthic Niclosamide as an Inhibitor of Lysosome Anterograde Trafficking and Prostate Cancer Cell Invasion | PLOS ONE
Frontiers | Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways
StudyPages - Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer
The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway - Journal of Surgical Research
Niclosamide reverses adipocyte induced epithelial-mesenchymal transition in breast cancer cells via suppression of the interleukin-6/STAT3 signalling axis | Scientific Reports
